ELDN icon

Eledon Pharmaceuticals

17 hedge funds and large institutions have $18.9M invested in Eledon Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$12.8M 2,537,110
LSC
2
Lyon Street Capital
California
$1.71M 338,929
BC
3
Boxer Capital
California
$1.64M 324,383 +324,383 New
RI
4
RTW Investments
New York
$1.51M 300,000 +300,000 New
Renaissance Technologies
5
Renaissance Technologies
New York
$554K 109,876 +16,600 +18%
Vanguard Group
6
Vanguard Group
Pennsylvania
$212K 43,911 +425 +1%
DC
7
Derby & Company
Massachusetts
$149K 29,545 +11,111 +60%
BlackRock
8
BlackRock
New York
$80K 15,753 -329 -2%
DS
9
DRW Securities
Illinois
$78K 15,489 +3,000 +24%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$72K 14,879 -800 -5%
PPA
11
Parametric Portfolio Associates
Washington
$67K 13,377 +13,377 New
Deutsche Bank
12
Deutsche Bank
Germany
$17K 3,547 +3,543 New
UBS Group
13
UBS Group
Switzerland
$13K 2,547 -1,166 -31%
MAM
14
Meeder Asset Management
Ohio
$4K 755 -329 -30%
TRCT
15
Tower Research Capital (TRC)
New York
$1K 294 -1,221 -81%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
-1 -100%
Barclays
17
Barclays
United Kingdom
$0 20 +18 New
Bank of America
18
Bank of America
North Carolina
$0 68 +68 New